Communication barriers between basic scientists and clinicians in regenerative medicine: A qualitative study from Iran.

basic scientists clinicians communication barriers regenerative medicine translational science

Journal

Journal of evaluation in clinical practice
ISSN: 1365-2753
Titre abrégé: J Eval Clin Pract
Pays: England
ID NLM: 9609066

Informations de publication

Date de publication:
Aug 2021
Historique:
revised: 10 08 2020
received: 05 05 2020
accepted: 11 08 2020
pubmed: 3 9 2020
medline: 12 8 2021
entrez: 3 9 2020
Statut: ppublish

Résumé

Cell-based therapeutics are among the latest advances in health care technologies. The rapid evolution of stem cell science in Iran has necessitated the application of scientific achievements in clinical settings. However, various issues hindered their translation, in particular, impediments in the interactions of basic stem cell scientists and clinicians. We highlighted the impediments in the interactions of stem cell scientists and physicians involved in the opinion of professionals from both groups. This qualitative research was conducted with thematic analysis, performed by purposive sampling. Thirty-two distinguished stem cell scientists and clinicians were interviewed to identify their perspectives on this matter. MAXQDA 2018 was used to classify the axial codes based on factors related to communications inefficiencies. The analysis of coded data recognized 18 subthemes and six major themes. Central themes include different registers of the two parties, counterproductive clusters hampered networking, external communication barriers, the competition to access resources, leadership conflicts, and the dissatisfaction of stakeholders with their share. Most of the impediments were seemingly global, for example, the incoherent medical and basic science educational systems, the vulnerable career path of physician-scientists, and an increasing tendency towards overspecialization. However, some local specific issues were also described, for example, limited funding opportunities and the negative impacts of the division of medical education from the ministry of science, research, and technology in Iran. Proposed interventions include the reinforcement of physician-scientist programs, designing a distributed leadership model, and bringing back the scientific integrity to higher education in Iran.

Identifiants

pubmed: 32876983
doi: 10.1111/jep.13472
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

799-808

Informations de copyright

© 2020 John Wiley & Sons Ltd.

Références

Glasgow RE, Emmons KM. How can we increase translation of research into practice? Types of evidence needed. Annu Rev Public Health. 2007;28:413-433. https://doi.org/10.1146/annurev.publhealth.28.021406.144145.
Hobin JA, Deschamps AM, Bockman R, et al. Engaging basic scientists in translational research: identifying opportunities, overcoming obstacles. J Transl Med. 2012;10:72. https://doi.org/10.1186/1479-5876-10-72.
Hammes SR, Lange CA. Lost in translation: can we afford to miss the trees for the forest? Horm Cancer. 2014;5(4):203-206. https://doi.org/10.1007/s12672-014-0187-9.
Burningham S, Ollenberger A, Caulfield T. Commercialization and stem cell research: a review of emerging issues. Stem Cells Dev. 2013;22(Suppl 1):80-84. https://doi.org/10.1089/scd.2013.0317.
Risbridger GP. Editorial: the future of our basic science and scientists. Mol Endocrinol. 2015;29(12):1673-1674. https://doi.org/10.1210/me.2015-1284.
Cuende N, Izeta A. Clinical translation of stem cell therapies: a bridgeable gap. Cell Stem Cell. 2010;6(6):508-512. https://doi.org/10.1016/j.stem.2010.05.005.
Rahman S, Majumder MA, Shaban SF, et al. Physician participation in clinical research and trials: issues and approaches. Adv Med Educ Pract. 2011;2:85-93. https://doi.org/10.2147/AMEP.S14103.
Yanagawa H, Kishuku M, Akaike M, Azuma H, Irahara M. View of physicians on and barriers to patient enrollment in a multicenter clinical trial: experience in a Japanese rural area. Int Arch Med. 2010;3:7. https://doi.org/10.1186/1755-7682-3-7.
Smyth JF, Mossman J, Hall R, et al. Conducting clinical research in the new NHS: the model of cancer. United Kingdom Coordinating Committee on Cancer Research. BMJ. 1994;309(6952):457-461. https://doi.org/10.1136/bmj.309.6952.457.
Dickinson CJ. Clinical research in the NHS today. J R Coll Physicians Lond. 1994;28(5):460-463.
Albers LL, Sedler KD. Clinician perspectives on participation in research. J Midwifery Womens Health. 2004;49(1):47-50. https://doi.org/10.1016/j.jmwh.2003.09.013.
Ellis PM, Butow PN, Simes RJ, Tattersall MH, Dunn SM. Barriers to participation in randomized clinical trials for early breast cancer among Australian cancer specialists. Aust N Z J Surg. 1999;69(7):486-491. https://doi.org/10.1046/j.1440-1622.1999.01608.x.
Sumi E, Murayama T, Yokode M. A survey of attitudes toward clinical research among physicians at Kyoto University Hospital. BMC Med Educ. 2009;9:75. https://doi.org/10.1186/1472-6920-9-75.
DeMaria AN. Clinical investigation…An impending crisis? J Am Coll Cardiol. 2003;41(11):2100-2101. https://doi.org/10.1016/s0735-1097(03)00567-9.
Fordyce CB, Roe MT, Pierre C, et al. Trends in clinical trial investigator workforce and turnover: an analysis of the U.S. FDA 1572 BMIS database. Contemp Clin Trials Commun. 2019;15:100380. https://doi.org/10.1016/j.conctc.2019.100380.
Wilson-Kovacs DM, Hauskeller C. The clinician-scientist: professional dynamics in clinical stem cell research. Sociol Health Illn. 2012;34(4):497-512. https://doi.org/10.1111/j.1467-9566.2011.01389.x.
Beckett M, Quiter E, Ryan G, et al. Bridging the gap between basic science and clinical practice: the role of organizations in addressing clinician barriers. Implement Sci. 2011;6:35. https://doi.org/10.1186/1748-5908-6-35.
Heathman TR, Nienow AW, McCall MJ, Coopman K, Kara B, Hewitt CJ. The translation of cell-based therapies: clinical landscape and manufacturing challenges. Regen Med. 2015;10(1):49-64. https://doi.org/10.2217/rme.14.73.
Frati P, Scopetti M, Santurro A, Gatto V, Fineschi V. Stem cell research and clinical translation: a roadmap about good clinical practice and patient care. Stem Cells Int. 2017;2017:5080259. https://doi.org/10.1155/2017/5080259.
Vrtovec B, Bolli R. Potential strategies for clinical translation of repeated cell therapy. Circ Res. 2019;124(5):690-692. https://doi.org/10.1161/CIRCRESAHA.118.314653.
Bieback K, Kinzebach S, Karagianni M. Translating research into clinical scale manufacturing of mesenchymal stromal cells. Stem Cells Int. 2011;2010:193519. https://doi.org/10.4061/2010/193519.
Mankoff SP, Brander C, Ferrone S, Marincola FM. Lost in translation: obstacles to translational medicine. J Transl Med. 2004;2(1):14. https://doi.org/10.1186/1479-5876-2-14.
Coller BS, Califf RM. Traversing the valley of death: a guide to assessing prospects for translational success. Sci Transl Med. 2009;1(10):10cm9. https://doi.org/10.1126/scitranslmed.3000265.
Fernandez-Moure JS. Lost in translation: the gap in scientific advancements and clinical application. Front Bioeng Biotechnol. 2016;4:43. https://doi.org/10.3389/fbioe.2016.00043.
Fudge N, Sadler E, Fisher HR, Maher J, Wolfe CD, McKevitt C. Optimising translational research opportunities: a systematic review and narrative synthesis of basic and clinician scientists' perspectives of factors which enable or hinder translational research. PLoS One. 2016;11(8):e0160475. https://doi.org/10.1371/journal.pone.0160475.
de Wilde S, Guchelaar HJ, Zandvliet ML, Meij P. Clinical development of gene- and cell-based therapies: overview of the European landscape. Mol Ther Methods Clin Dev. 2016;3:16073. https://doi.org/10.1038/mtm.2016.73.
Sahs JA, Nicasio AV, Storey JE, Guarnaccia PJ, Lewis-Fernandez R. Developing research collaborations in an academic clinical setting: challenges and lessons learned. Community Ment Health J. 2017;53(6):647-660. https://doi.org/10.1007/s10597-016-0073-8.
Trounson A, Baum E, Gibbons D, Tekamp-Olson P. Developing a case study model for successful translation of stem cell therapies. Cell Stem Cell. 2010;6(6):513-516. https://doi.org/10.1016/j.stem.2010.05.008.
Gheisari Y, Baharvand H, Nayernia K, Vasei M. Stem cell and tissue engineering research in the Islamic Republic of Iran. Stem Cell Rev Rep. 2012;8(3):629-639. https://doi.org/10.1007/s12015-011-9343-6.
Miremadi T, Salekdeh GH, Aghdami N, et al. Stem cell research and therapy in the Islamic Republic of Iran: pioneering in the Islamic world. Stem Cells Dev. 2013;22(1):51-57. https://doi.org/10.1089/scd.2012.0195.
Van Noorden R. 365 days: 2011 in review. Nature. 2011;480(7378):426-429. https://doi.org/10.1038/480426a.
Jaenisch R. An American scientist in Tehran. Nat Rep Stem Cells. 2007(1):1-1. https://doi.org/10.1038/stemcells.2007.105.
Baharvand H, Ashtiani SK, Valojerdi MR, Shahverdi A, Taee A, Sabour D. Establishment and in vitro differentiation of a new embryonic stem cell line from human blastocyst. Differentiation. 2004;72(5):224-229. https://doi.org/10.1111/j.1432-0436.2004.07205005.x.
Baharvand H, Ashtiani SK, Taee A, et al. Generation of new human embryonic stem cell lines with diploid and triploid karyotypes. Dev Growth Differ. 2006;48(2):117-128. https://doi.org/10.1111/j.1440-169X.2006.00851.x.
Bidkhori HR, Bahrami AR, Miri R, et al. Issues distance stem cell research achievements from being applied in translational medicine: a qualitative study from Iran. Paper presented at: International Society for Stem Cell Research 11th Annual Meeting; June 12-15, 2013; Boston MA. https://www.isscr.org/docs/default-source/am2013-support-documents/isscr2013-poster-abstracts.pdf?sfvrsn=09. Accessed May 20, 2020.
Shaiegan M. Stem cell therapy and research status in Iran: at a glance. Iran J Blood Cancer. 2010;2(3):99-100.
Furuya H, Brenner D, Rosser CJ. On the brink of extinction: the future of translational physician-scientists in the United States. J Transl Med. 2017;15(1):88. https://doi.org/10.1186/s12967-017-1188-6.
DeFranco DB, Sowa G. The importance of basic science and research training for the next generation of physicians and physician scientists. Mol Endocrinol. 2014;28(12):1919-1921. https://doi.org/10.1210/me.2014-1343.
Fayter D, McDaid C, Eastwood A. A systematic review highlights threats to validity in studies of barriers to cancer trial participation. J Clin Epidemiol. 2007;60(10):990-1001. https://doi.org/10.1016/j.jclinepi.2006.12.013.
Holden G, Rosenberg G, Barker K, Tuhrim S, Brenner B. The recruitment of research participants: a review. Soc Work Health Care. 1993;19(2):1-44. https://doi.org/10.1300/J010v19n02_01.
Stone C, Dogbey GY, Klenzak S, Van Fossen K, Tan B, Brannan GD. Contemporary global perspectives of medical students on research during undergraduate medical education: a systematic literature review. Med Educ Online. 2018;23(1):1537430. https://doi.org/10.1080/10872981.2018.1537430.
Abu-Zaid A, Alkattan K. Integration of scientific research training into undergraduate medical education: a reminder call. Med Educ Online. 2013;18:22832. https://doi.org/10.3402/meo.v18i0.22832.
Gilbert GH, Cochran DL, Fellows JL, et al. Engaging clinicians in research. J Am Dent Assoc. 2018;149(12):1007-1008. https://doi.org/10.1016/j.adaj.2018.10.005.
Littlewood S, Ypinazar V, Margolis SA, Scherpbier A, Spencer J, Dornan T. Early practical experience and the social responsiveness of clinical education: systematic review. BMJ. 2005;331(7513):387-391. https://doi.org/10.1136/bmj.331.7513.387.
Brown M, Barnes J, Silver K, Williams N, Newton PM. The educational impact of exposure to clinical psychiatry early in an undergraduate medical curriculum. Acad Psychiatry. 2016;40(2):274-281. https://doi.org/10.1007/s40596-015-0358-1.
Schafer AI, Mann DL. Current education of physicians: lost in translation? JACC Basic Transl Sci. 2019;4(5):655-657. https://doi.org/10.1016/j.jacbts.2019.08.002.
Zemlo TR, Garrison HH, Partridge NC, Ley TJ. The physician-scientist: career issues and challenges at the year 2000. FASEB J. 2000;14(2):221-230. https://doi.org/10.1096/fasebj.14.2.221.
Roberts SF, Fischhoff MA, Sakowski SA, Feldman EL. Perspective: transforming science into medicine: how clinician-scientists can build bridges across research's "valley of death". Acad Med. 2012;87(3):266-270. https://doi.org/10.1097/ACM.0b013e3182446fa3.
Rosenberg L. Physician-scientists--endangered and essential. Science. 1999;283(5400):331-332. https://doi.org/10.1126/science.283.5400.331.
Blish CA. Maintaining a robust pipeline of future physician-scientists. J Infect Dis. 2018;218(suppl_1):S40-S43. https://doi.org/10.1093/infdis/jiy093.
Wyngaarden JB. The clinical investigator as an endangered species. N Engl J Med. 1979;301(23):1254-1259. https://doi.org/10.1056/NEJM197912063012303.
Brown NJ. Developing physician-scientists. Circ Research. 2018;123(6):645-647. https://doi.org/10.1161/CIRCRESAHA.118.313473.
Feldman AM. The National Institutes of Health Physician-Scientist Workforce Working Group report: a roadmap for preserving the physician-scientist. Clin Transl Sci. 2014;7(4):289-290. https://doi.org/10.1111/cts.12209.
Cranley LA, Cummings GG, Profetto-McGrath J, Toth F, Estabrooks CA. Facilitation roles and characteristics associated with research use by healthcare professionals: a scoping review. BMJ Open. 2017;7(8):e014384. https://doi.org/10.1136/bmjopen-2016-014384.
Floor WM. Public Health in Qajar Iran. (Vol. 14). Washington, DC: Mage Publishers; 2004.
Azizi MH. The historical backgrounds of the ministry of health foundation in Iran. Arch Iran Med. 2007;10(1):119-123.
Ebrahimnejad H. Medicine, Public Health, and the Qājār State: Patterns of Medical Modernization in Nineteenth-Century Iran. Vol 4. Leiden, Netherlands: Brill; 2004.
Marandi SA. The integration of Medical Education and Health Care Services in the I.R. of Iran and its health impacts. Iran J Public Health. 2009;38(Supple 1):4-12.
Gilavand A, Mehralizadeh Y, Hosseinpour M, Torabipour A. A review on pathology of the integration of Medical Education System with Health Services at Iran's Ministry of Health and Medical Education. Future Med Educ J. 2018;8(3):47-56.
Marandi A. Integrating medical education and health services: the Iranian experience. Med Educ. 1996;30(1):4-8. https://doi.org/10.1111/j.1365-2923.1996.tb00709.x.
Anderlini D. The United States health care system is sick: from Adam Smith to overspecialization. Cureus. 2018;10(5):e2720. https://doi.org/10.7759/cureus.2720.
Makary MA, Daniel M. Medical error-the third leading cause of death in the US. BMJ. 2016;353(353):i2139. https://doi.org/10.1136/bmj.i2139.
Barnett K, Mercer SW, Norbury M, Watt G, Wyke S, Guthrie B. Epidemiology of multimorbidity and implications for health care, research, and medical education: a cross-sectional study. Lancet. 2012;380(9836):37-43. https://doi.org/10.1016/S0140-6736(12)60240-2.
Namazi H, Aramesh K, Larijani B. The doctor-patient relationship: toward a conceptual re-examination. J Med Ethics Hist Med. 2016;9:10.
Jay M. Habermas and modernism. Prax Int. 1984;4(1):1-14.
Restifo LL, Phelan GR. The cultural divide: exploring communication barriers between scientists and clinicians. Dis Model Mech. 2011;4(4):423-426. https://doi.org/10.1242/dmm.008177.
Trowler P. Academic tribes and territories: the theoretical trajectory. Österreichische Zeitschrift Für Geschichtswissenschaften. 2014;25(3):17-26.
Trowler PR. Academic Tribes and Territories. UK: McGraw-Hill Education; 2001.
Currie G, Lockett A, Finn R, Martin G, Waring J. Institutional work to maintain professional power: recreating the model of medical professionalism. Organ. Stud. 2012;33(7):937-962.
Trowler P, Saunders M, Bamber V. Conclusion: academic practices and the disciplines in the 21st century. In: Trowler P, Saunders M, Bamber V, eds. Tribes and Territories in the 21st Century. UK: Routledge; 2012:252-269.
Barry D. Managing the bossless team: lessons in distributed leadership. Organ Dyn. 1991;20(1):31-47.
Long JC, Cunningham FC, Carswell P, Braithwaite J. Patterns of collaboration in complex networks: the example of a translational research network. BMC Health Serv Res. 2014;14:225. https://doi.org/10.1186/1472-6963-14-225.
Storey A. The problem of distributed leadership in schools. School Leadership Manage. 2004;24(3):249-265.

Auteurs

Hamid Reza Bidkhori (HR)

Stem Cells and Regenerative Medicine Research Department, Academic Center for Education, Culture, and Research (ACECR)-Khorasan Razavi, Mashhad, Iran.

Ahmad Reza Bahrami (AR)

Department of Biology, Faculty of Science, Ferdowsi University of Mashhad, Mashhad, Iran.

Shadi Mehrzad (S)

Stem Cells and Regenerative Medicine Research Department, Academic Center for Education, Culture, and Research (ACECR)-Khorasan Razavi, Mashhad, Iran.

Hamed Bakhshi (H)

Social Sciences Research Department, Academic Center for Education, Culture, and Research (ACECR)-Khorasan Razavi, Mashhad, Iran.

Rahele Miri (R)

Blood-Borne Infections Research Center, Academic Center for Education, Culture, and Research (ACECR)-Khorasan Razavi, Mashhad, Iran.

Mohammad Reza Hedayati-Moghaddam (MR)

Blood-Borne Infections Research Center, Academic Center for Education, Culture, and Research (ACECR)-Khorasan Razavi, Mashhad, Iran.

Bardia Shabani (B)

History of economic thought department, Paul Valéry - Montpellier III University, Route de Mende, Montpellier, France.

Halimeh Hasanzadeh (H)

Stem Cells and Regenerative Medicine Research Department, Academic Center for Education, Culture, and Research (ACECR)-Khorasan Razavi, Mashhad, Iran.

Majid Danaee (M)

Social Sciences Research Department, Academic Center for Education, Culture, and Research (ACECR)-Khorasan Razavi, Mashhad, Iran.
Blood-Borne Infections Research Center, Academic Center for Education, Culture, and Research (ACECR)-Khorasan Razavi, Mashhad, Iran.

Seyed Aliakbar Shamsian (SA)

Blood-Borne Infections Research Center, Academic Center for Education, Culture, and Research (ACECR)-Khorasan Razavi, Mashhad, Iran.

Arash Akhavan-Rezayat (A)

Clinical Research Development Unit, Imam Reza Hospital, Mashhad University of Medical Sciences, Mashhad, Iran.

Parisa Mohebbi (P)

Anesthesiology Department, Razavi Hospital, Mashhad, Iran.

Farahnaz Rohani (F)

Clinical Research Development Unit, Imam Reza Hospital, Mashhad University of Medical Sciences, Mashhad, Iran.

Maryam M Matin (M)

Department of Biology, Faculty of Science, Ferdowsi University of Mashhad, Mashhad, Iran.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH